 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Treatment Action Group
Cohort Studies Suggesting Immediate HAART Confers No Extra Benefit Compared with Deferred HAART in HIV-Infected Persons CD4 >200 cells/mm3March 2000 This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.
Back to the TAGline March, 2000 contents page.
This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document. This article was provided by Treatment Action Group. It is a part of the publication TAGline.
|
 |
||||||||||||||||||||||||||||
E-Mail
Printable Single-Page
Glossary
Share
